Navigation Links
eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
Date:7/23/2008

ture will first deploy mySHOP 3.0 in a pilot stage covering Tiens Group's four subsidiary stores, four direct-sales stores and 40 franchised chain stores in China and expects the pilot stage to be operational by December 2008. After the completion of an initial rollout, eFuture and Tiens Group expect to further collaborate to complete a nationwide expansion of the system to a further 96 subsidiary stores, 96 direct-sales stores and 1,000 franchised chain stores in 2009.

In July 2006, Tiens Group selected eFuture's ONE POS-ERP R2003 Super Market Management System for its Bannerstore Supermarket. Since its selection, the R2003 Super Market Management system has been successfully implemented in Bannerstore's headquarters back-office, six subsidiary stores, 17 direct-sales stores and 23 franchised chain stores.

About Tiens Group Co., Ltd.

Founded in 1995 by Mr. Li Jinyuan, Tiens Group Co., Ltd. (Amex: TBV) is a large-scale global enterprise with operations in over 190 countries and regions and with a customer base of over 16 million worldwide. Since 1995, Tiens Group has maintained continual, stable, and rapid growth. With an anchor business in advanced biotechnology, particularly in the areas of health food, health care, beauty care and home care products, Tiens Group is also involved in financing, real estate development, education, cultural exchanges, and modern logistics. Tiens Group is headquartered at the Henderson Center in Beijing, China, and has production plants in the Wuqing New Technology Development Zone of Tianjin, China.

Tiens Group is a direct selling company that is based on advanced biotechnology devoted to developing health and wellness products and a culture for a healthy lifestyle. Tiens Group operates
'/>"/>

SOURCE eFuture Information Technology Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
2. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
3. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis
4. Sigma-Aldrich Signs Agreement With Plextronics to Distribute Plexcore(R) Organic Electronics Materials
5. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
6. Medline Signs 3-Year Purchasing Agreement for Mouth Rinse From Chester Labs
7. Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
8. Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
9. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
10. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
11. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Rockville, MD (PRWEB) September 17, 2014 ... Small Business Innovation Research (SBIR) grant to support the ... award will provide ITI with approximately $255,000 over one ... a leading cause of food allergy, affect over one ... anaphylaxis behind peanut allergy. Tree nut exposure is also ...
(Date:9/17/2014)... , Sept. 17, 2014 Intarcia Therapeutics, ... data from a study of the cost and predictability ... 50 th Annual Meeting of the European Association ... session today, Christian Frois , Ph.D., of Analysis ... series of planned Intarcia-sponsored, retrospective studies to characterize the ...
(Date:9/17/2014)... LAUDERDALE, Fla. , Sept. 17, 2014 Alternative ... an agreement to form a Special Purpose Vehicle in partnership ... based Jatropha centric agro energy company. The SPV shall be ... registered entity with AFAI as majority shareholder. The SPV shall ... Africa , particularly Ethiopia . ...
(Date:9/17/2014)... FRANCISCO, Calif. , Sept. 17, 2014 ... a molecular diagnostics company pioneering the field of molecular ... to chief operating officer. Mr. Hall joined ... the company,s commercial entry into endocrinology. Since 2012, he ... as well as managed care and billing functions. As ...
Breaking Biology Technology:Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4
... slogans and catchy buzz-phrases to capture the media spotlight as ... equals broadband connectivity (EDEBC) is one of those slogans. ... the test of time. Otherwise, it fades faster than the ... EDEBC is becoming very proven because future economic viability is ...
... advice and $25,000 in cash prizes will be at ... 2007 Northeast Wisconsin Business Plan Contest . , ... existing businesses that are changing direction, in northeastern Wisconsin. ... place reward, entrepreneurs will receive advice about crafting their ...
... - An early-stage company developing diagnostics to test for kidney ... investments to secure federal clearance for its first clinical product. ... of $3.2 million since its inception in 1999, will use ... research and development activities. ,The round was led by Appleton-based ...
Cached Biology Technology:Locations must have connectivity to be viable 2Locations must have connectivity to be viable 3Locations must have connectivity to be viable 4Renovar captures $1.2M for product development 2
(Date:9/17/2014)... professor and his doctoral student have designed a device ... collected from fog and dew., The device could provide ... around the globe., Cheng Luo, professor in the Mechanical ... in the same College of Engineering department, published "Bioinspired ... ACS, (American Chemical Society) Applied Materials & ...
(Date:9/17/2014)... Evolution and Yale University offers compelling support for the ... partially predict the likelihood of being diagnosed with mental ... life. The study analyzed medical records of 1.75 million ... 30 years, and adjusted for almost all other known ... Proceedings of the Royal Society, London B . ...
(Date:9/17/2014)... UTSouthwestern Medical Center have found that the most common ... helps repair the lining of blood vessels. Individuals with ... of this repair, putting them at higher risk for ... one mechanism by which apoE3 promotes a healthy cardiovascular ... said Dr. Philip Shaul , Professor of Pediatrics ...
Breaking Biology News(10 mins):Shorebird's beak inspires UT Arlington research on water collection 2Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3Protein variant may boost cardiovascular risk by hindering blood vessel repair 2
... codes of over 40,000 women -- including those ... disease – has uncovered five common genetic variants that ... a paper published online today in the journal Nature, ... association study report that these five genes code for ...
... of the Health Sciences (USU) suggests that it may ... the myriad strains of the HIV virus. HIV is ... stimulate the body to produce cross-reactive antibodies that will ... of truly broad-spectrum neutralizing antibodies may be an achievable ...
... disease typically characterized by the slow but progressive onset ... about five years after diagnosis. However, according to a ... PLoS ONE, a subset of patients with a specific ... complete pulmonary failure and death without a lung transplant. ...
Cached Biology News:First confirmed common genetic risk factors for breast cancer 2Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients 2
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
... microarrays are derived from Paraffin embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
... are derived from frozen embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... are large (3-5mm in diameter) in comparison ...
Biology Products: